PDGFB and uterine corpus sarcoma: As the clinical signs and symptoms in patients with COL1A1–PDGFB fusion uterine sarcomas in the female genital tract were usually silent in early stages, two out of six patients were initially diagnosed at late stages (IIIB and IVA in cases 2 and 4) as shown in Table 2.